Edgar Filing: MAXIM INTEGRATED PRODUCTS INC

Maxim Q3'14 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)



[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 29, 2014



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from ________ to ________.

Commission file number 1-34192

MAXIM INTEGRATED PRODUCTS, INC.

(Exact name of Registrant as Specified in its Charter)



Delaware (State or Other Jurisdiction of Incorporation or Organization)		94-2896096 (I.R.S. Employer I. D. No.)

160 Rio Robles

San Jose, California 95134

(Address of Principal Executive Offices including Zip Code)

(408) 601-1000

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES [x] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [x] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller” reporting company in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer [x]	Accelerated filer [ ]	Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). (Check one):

YES [ ] NO [x]

As of April 17, 2014 there were 282,713,828 shares of Common Stock, par value $.001 per share, of the registrant outstanding.

MAXIM INTEGRATED PRODUCTS, INC.

INDEX



PART I - FINANCIAL INFORMATION		Page

Item 1. Financial Statements (Unaudited)		3

Condensed Consolidated Balance Sheets as of March 29, 2014 and June 29, 2013		3

Condensed Consolidated Statements of Income for the Three and Nine Months Ended March 29, 2014 and March 30, 2013		4

Condensed Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended March 29, 2014 and March 30, 2013		5

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 29, 2014 and March 30, 2013		6

Notes to Condensed Consolidated Financial Statements		7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		24

Item 3. Quantitative and Qualitative Disclosures About Market Risk		29

Item 4. Controls and Procedures		29

PART II - OTHER INFORMATION		31

Item 1. Legal Proceedings		31

Item 1A. Risk Factors		31

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		31

Item 3. Defaults Upon Senior Securities		31

Item 4. Mine Safety Disclosures		31

Item 5. Other Information		31

Item 6. Exhibits		32

SIGNATURES		33

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)



	March 29, 2014			June 29, 2013
	(in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	1,231,248		$	1,174,986
Short-term investments	—			25,060
Total cash, cash equivalents and short-term investments	1,231,248			1,200,046
Accounts receivable, net	304,128			285,438
Inventories	290,518			275,640
Deferred tax assets	74,038			82,173
Other current assets	79,346			96,609
Total current assets	1,979,278			1,939,906
Property, plant and equipment, net	1,355,268			1,373,124
Intangible assets, net	384,167			157,146
Goodwill	597,676			422,004
Other assets	38,176			43,730
TOTAL ASSETS	$	4,354,565		$	3,935,910

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	94,315		$	105,322
Income taxes payable	20,720			22,437
Accrued salary and related expenses	168,336			187,970
Accrued expenses	81,232			60,592
Current portion of long-term debt	2,526			2,015
Deferred revenue on shipments to distributors	24,259			26,557
Total current liabilities	391,388			404,893
Long-term debt	1,000,871			503,573
Income taxes payable	352,294			282,697
Deferred tax liabilities	171,431			206,855
Other liabilities	37,977			29,894
Total liabilities	1,953,961			1,427,912

Commitments and contingencies (Note 11)

Stockholders’ equity:
Common stock and capital in excess of par value	283			288
Retained earnings	2,412,627			2,523,457
Accumulated other comprehensive loss	(12,306		)	(15,747		)
Total stockholders’ equity	2,400,604			2,507,998
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	$	4,354,565		$	3,935,910

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)



	Three Months Ended						Nine Months Ended
	March 29, 2014			March 30, 2013			March 29, 2014			March 30, 2013
	(in thousands, except per share data)

Net revenues	$	605,681		$	604,884		$	1,811,196		$	1,833,265
Cost of goods sold	265,744			228,782			795,391			708,097
Gross margin	339,937			376,102			1,015,805			1,125,168
Operating expenses:
Research and development	141,493			134,138			414,366			402,810
Selling, general and administrative	80,680			81,954			241,581			242,199
Intangible asset amortization	4,863			3,903			13,267			11,855
Impairment of long-lived assets	—			—			5,197			24,929
Severance and restructuring expenses	3,338			151			19,112			2,387
Acquisition-related costs	(88		)	—			6,983			—
Other operating expenses (income), net	2,913			1,678			9,558			3,759
Total operating expenses	233,199			221,824			710,064			687,939
Operating income	106,738			154,278			305,741			437,229
Interest and other income (expense), net	5,174			(2,669		)	(4,122		)	(11,209		)
Income before provision for income taxes	111,912			151,609			301,619			426,020
Income tax provision (benefit)	(10,632		)	22,824			31,602			92,725
Income from continuing operations	122,544			128,785			270,017			333,295
Income from discontinued operations, net of tax	—			2,603			—			2,603
Net income	$	122,544		$	131,388		$	270,017		$	335,898

Earnings per share: Basic
From continuing operations	$	0.43		$	0.44		$	0.95		$	1.14
From discontinued operations	—			0.01			—			0.01
Basic	$	0.43		$	0.45		$	0.95		$	1.15

Earnings per share: Diluted
From continuing operations	$	0.42		$	0.43		$	0.93		$	1.11
From discontinued operations	—			0.01			—			0.01
Diluted	$	0.42		$	0.44		$	0.93		$	1.12

Shares used in the calculation of earnings per share:
Basic	282,627			292,888			283,315			292,048
Diluted	288,575			300,082			289,122			298,821

Dividends paid per share	$	0.26		$	0.24		$	0.78		$	0.72

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)



	Three Months Ended						Nine Months Ended
	March 29, 2014			March 30, 2013			March 29, 2014			March 30, 2013
	(in thousands)
Net income	$	122,544		$	131,388		$	270,017		$	335,898
Other comprehensive income, net of tax:
Change in net unrealized gains and losses on available-for-sale securities	—			(64		)	(23		)	(166		)
Change in net unrealized gains and losses on cash flow hedges	313			(631		)	870			(248		)
Change in net unrealized gains and losses on post-retirement benefits	285			405			852			1,659
Tax effect of the unrealized exchange gains and losses on long-term intercompany receivables	(335		)	(1,885		)	1,742			(3,433		)
Other comprehensive income (loss)	263			(2,175		)	3,441			(2,188		)
Total comprehensive income	$	122,807		$	129,213		$	273,458		$	333,710

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)



	Nine Months Ended
	March 29, 2014			March 30, 2013
	(in thousands)
Cash flows from operating activities:
Net income	$	270,017		$	335,898
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	63,666			64,955
Depreciation and amortization	180,202			155,945
Deferred taxes	(22,658		)	28,185
In-process research and development written-off	2,580			2,800
Loss (gain) from sale of property, plant and equipment	1,119			(2,536		)
Tax benefit (shortfall) related to stock-based compensation	(1,010		)	7,839
Impairment of long-lived assets	5,197			24,929
Impairment of investments in privately-held companies	3,723			—
Excess tax benefit from stock-based compensation	(9,295		)	(16,131		)
Loss (gain) on sale of discontinued operations	—			(3,285		)
Changes in assets and liabilities:
Accounts receivable	5,040			17,415
Inventories	19,446			(27,588		)
Other current assets	18,978			(18,401		)
Accounts payable	(16,458		)	(25,549		)
Income taxes payable	44,639			57,038
Deferred revenue on shipments to distributors	(2,298		)	(429		)
All other accrued liabilities	(20,865		)	2,450
Net cash provided by (used in) operating activities	542,023			603,535

Cash flows from investing activities:
Purchase of property, plant and equipment	(108,869		)	(167,750		)
Proceeds from sale of property, plant and equipment	3,666			14,658
Payments in connection with business acquisitions, net of cash acquired	(459,256		)	—
Proceeds from maturity of available-for-sale securities	27,000			50,000
Net cash provided by (used in) investing activities	(537,459		)	(103,092		)

Cash flows from financing activities:
Excess tax benefit from stock-based compensation	9,295			16,131
Contingent consideration paid	(4,705		)	(7,476		)
Repayment of notes payable	(2,278		)	(1,201		)
Issuance of debt	497,895			491,145
Debt issuance cost	(3,431		)	—
Net issuance of restricted stock units	(22,462		)	(21,586		)
Proceeds from stock options exercised	43,407			65,293
Issuance of ESPP shares under employee stock purchase program	19,096			16,768
Repurchase of common stock	(264,570		)	(181,914		)
Dividends paid	(220,549		)	(210,683		)
Net cash provided by (used in) financing activities	51,698			166,477
Net increase (decrease) in cash and cash equivalents	56,262			666,920
Cash and cash equivalents:
Beginning of period	1,174,986			881,060
End of period	$	1,231,248		$	1,547,980
Supplemental disclosures of cash flow information:
Cash paid (refunded), net during the period for income taxes	$	(11,185	)	$	13,115
Cash paid for interest	$	16,801		$	5,377
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$	11,916		$	19,171
Fair value of notes receivable assumed on sale of assets held for sale and discontinued operations	$	—		$	15,290

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

NOTE 1: BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair presentation have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 29, 2014 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated interim financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the fiscal year ended June 29, 2013. The Condensed Consolidated Financial Statements included in this Quarterly Report include the financial results of Volterra Semiconductor Corporation (“Volterra”) prospectively from the date of acquisition. Refer to Note 13: “Acquisitions” of these Notes to Condensed Consolidated Interim Financial Statements for further discussion in relation to Volterra.

The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal years 2014 and 2013 are 52-week fiscal years.

NOTE 2: RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

(i) New Accounting Updates Recently Adopted

In the first quarter of fiscal year 2014, the Company adopted Accounting Standards Update (“ASU”) No. 2013-02, Comprehensive Income (Topic 220)- Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income that requires reclassification adjustments from other comprehensive income to be presented either in the financial statements or in the notes to the financial statements. The adoption of this amended standard resulted in the presentation of the reclassification adjustments in the Notes to the Company's Condensed Consolidated Financial Statements. Refer to Note 9: “Comprehensive income” for the disclosure requirements provided.

(ii) Recent Accounting Updates Not Yet Effective

In July 2013, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2013-11, Income Taxes (Topic 740)-Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (“ASU 2013-11”). ASU 2013-11 requires certain unrecognized tax benefits to be presented as reductions to deferred tax assets instead of liabilities on the Condensed Consolidated Balance Sheets. The Company will be required to adopt ASU 2013-11 on a prospective basis in the first quarter of fiscal year 2015; however, early adoption is permitted, as is a retrospective application. The Company is currently evaluating the impact of this new standard on its Condensed Consolidated Balance Sheets.

In April 2014, the FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. ASU 2014-08 redefines discontinued operations as disposals representing a strategic shift in operations and having a major effect on the organization’s operations and financial results. The Company is currently evaluating the potential impact of this standard on its financial statements. The Company will be required to adopt ASU 2014-08 on a prospective basis starting in fiscal year 2016.

NOTE 3: BALANCE SHEET COMPONENTS

Accounts receivable, net consists of:



	March 29, 2014			June 29, 2013
Accounts Receivable:	(in thousands)
Accounts receivable	$	320,363		$	299,083
Returns and allowances	(16,235		)	(13,645		)
	$	304,128		$	285,438

Inventories consist of:



	March 29, 2014		June 29, 2013
Inventories:	(in thousands)
Raw materials	$	13,906	$	14,055
Work-in-process	186,249		184,511
Finished goods	90,363		77,074
	$	290,518	$	275,640

Property, plant and equipment, net consists of:



	March 29, 2014			June 29, 2013
Property, plant and equipment:	(in thousands)
Land	$	62,093		$	62,093
Buildings and building improvements	376,112			364,037
Machinery and equipment	2,146,411			2,099,301
	2,584,616			2,525,431
Less: accumulated depreciation and amortization	(1,229,348		)	(1,152,307		)
	$	1,355,268		$	1,373,124

NOTE 4: FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company’s Level 1 assets consist of money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company’s Level 2 assets and liabilities consist of certificates of deposit, government agency securities and foreign currency forward contracts.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company’s Level 3 consists of contingent consideration liability related to certain prior years’ acquisitions

Assets and liabilities measured at fair value on a recurring basis were as follows:



	As of March 29, 2014								As of June 29, 2013
	Fair Value Measurements Using						Total Balance		Fair Value Measurements Using						Total Balance
	Level 1		Level 2		Level 3		Total Balance		Level 1		Level 2		Level 3		Total Balance
	(in thousands)
Assets
Money market funds (1)	$	744,979	$	—	$	—	$	744,979	$	402,513	$	—	$	—	$	402,513
Certificates of deposit (1)	—		—		—		—		—		77		—		77
Government agency securities (2)	—		—		—		—		—		25,060		—		25,060
Foreign currency forward contracts (3)	—		157		—		157		—		187		—		187
Total Assets	$	744,979	$	157	$	—	$	745,136	$	402,513	$	25,324	$	—	$	427,837

Liabilities
Foreign currency forward contracts (4)	$	—	$	399	$	—	$	399	$	—	$	1,419	$	—	$	1,419
Contingent Consideration (4)	—		—		4,358		4,358		—		—		8,577		8,577
Total Liabilities	$	—	$	399	$	4,358	$	4,757	$	—	$	1,419	$	8,577	$	9,996

(1) Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets.

(2) Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets.

(3) Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets.

(4) Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets.

The tables below present reconciliations for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the nine months ended March 29, 2014 and March 30, 2013:



Fair Value Measured and Recorded Using Significant Unobservable Inputs (Level 3)

	March 29, 2014			March 30, 2013
Contingent Consideration	(in thousands)
Beginning balance	$	8,577		$	17,737
Total gains or losses (realized and unrealized):
Included in earnings	1,632			3,226
Payments	(5,851		)	(7,476		)
Ending balance	$	4,358		$	13,487

Changes in unrealized losses (gains) included in earnings related to liabilities still held as of period end	$	1,632		$	3,226

The valuation of contingent consideration is based on a probability weighted earnout model which relies primarily on estimates of milestone achievements and discount rates applicable for the period expected payout. The most significant unobservable input used in the determination of estimated fair value of contingent consideration is the estimates on the likelihood of milestone achievements, which directly correlates to the fair value recognized in the Condensed Consolidated Balance Sheets.

The fair value of this liability is estimated quarterly by management based on inputs received from the Company’s engineering and finance personnel. The determination of the milestone achievement is performed by the Company’s business units and reviewed by the accounting department. Potential valuation adjustments are made as the progress toward achieving milestones becomes determinable, with the impact of such adjustments being recorded to Other operating expenses (income), net.

During the nine months ended March 29, 2014 and the year ended June 29, 2013, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

There were no assets or liabilities measured at fair value on a non-recurring basis as of March 29, 2014 and June 29, 2013.

NOTE 5: FINANCIAL INSTRUMENTS

Short-term investments

Fair values were as follows:



	March 29, 2014								June 29, 2013
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
	(in thousands)
Available-for-sale investments
Government agency securities	$	—	$	—	$	—	$	—	$	25,024	$	36	$	—	$	25,060
Total available-for-sale investments	$	—	$	—	$	—	$	—	$	25,024	$	36	$	—	$	25,060

In the nine months ended March 29, 2014 and the year ended June 29, 2013, the Company did not recognize any impairment charges on short-term investments.

Derivative instruments and hedging activities

The Company generates less than 5% of its revenues in various global markets based on orders obtained in non-U.S. currencies, primarily the Japanese Yen, the Euro and the British Pound. The Company incurs expenditures denominated in non-U.S. currencies, including the Philippine Peso and Thai Baht associated with the Company’s manufacturing activities in the Philippines and Thailand, respectively, and expenditures for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to ASC 815 Derivatives and Hedging. As of March 29, 2014 and June 29, 2013, respectively, the notional amounts of the forward contracts we held to purchase U.S. Dollars in exchange for other international currencies were $52.9 million and $53.8 million, respectively, and the notional amounts of forward contracts we held to sell U.S. Dollars in exchange for other international currencies were $1.4 million and $3.2 million, respectively.

Derivatives not designated as hedging instruments

As of March 29, 2014 and June 29, 2013, respectively, the notional amounts of the forward contracts we held to purchase U.S. Dollars in exchange for other international currencies were $15.9 million and $15.0 million, respectively, and the notional amounts of forward contracts we held to sell U.S. Dollars in exchange for other international currencies were $31.1 million and $36.5 million, respectively. The fair values of our outstanding foreign currency forward contracts and amounts included in the condensed consolidated statement of income were not material for nine months ended March 29, 2014 and year ended June 29, 2013.

Long-term debt

The following table summarizes the Company’s long-term debt:



	March 29, 2014			June 29, 2013
	(in thousands)
3.375% fixed rate notes due March 2023	$	500,000		$	500,000
2.5% fixed rate notes due November 2018	500,000			—
Notes denominated in Euro
Amortizing floating rate notes (EURIBOR plus 1.5%) due up to June 2014	2,526			4,804
Term fixed rate notes (2.0%-2.5%) due up to September 2015	871			784
Total	1,003,397			505,588
Less: Current portion	(2,526		)	(2,015		)
Total long-term debt	$	1,000,871		$	503,573

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses, and are included in the financing activities in the Condensed Consolidated Statements of Cash Flows.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses, and are included in the financing activities in the Condensed Consolidated Statements of Cash Flows.

The 2018 Notes and the 2023 Notes are governed by a base indenture, dated June 10, 2010, and supplemental indentures, dated March 18, 2013 with respect to the 2023 Notes and November 21, 2013 with respect to the 2018 Notes, between the Company and Wells Fargo Bank, National Association, as trustee.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net over the life of the notes. Interest expense associated with the notes was $7.4 million and $3.8 million during the three months ended March 29, 2014 and March 30, 2013, respectively. Interest expense associated with the notes was $17.3 million and $9.6 million during the nine months ended March 29, 2014 and March 30, 2013, respectively. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income.

The estimated fair value of the Company’s debt was approximately $983 million as of March 29, 2014. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

Other Financial Instruments

For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

NOTE 6: STOCK-BASED COMPENSATION

The following table shows total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 29, 2014 and March 30, 2013:



	Three Months Ended
	March 29, 2014								March 30, 2013
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	451	$	2,108	$	594	$	3,153	$	337	$	2,120	$	598	$	3,055
Research and development	2,124		7,917		1,623		11,664		1,440		7,116		1,480		10,036
Selling, general and administrative	1,391		5,186		663		7,240		1,157		4,764		601		6,522
Pre-tax stock-based compensation expense	$	3,966	$	15,211	$	2,880	$	22,057	$	2,934	$	14,000	$	2,679	$	19,613
Less: income tax effect							3,400								2,847
Net stock-based compensation expense							$	18,657							$	16,766



	Nine Months Ended
	March 29, 2014								March 30, 2013
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	1,238	$	6,421	$	1,602	$	9,261	$	1,212	$	6,863	$	1,651	$	9,726
Research and development	6,576		23,085		4,098		33,759		5,557		24,727		4,215		34,499
Selling, general and administrative	4,131		14,709		1,806		20,646		3,998		15,035		1,697		20,730
Pre-tax stock-based compensation expense	$	11,945	$	44,215	$	7,506	$	63,666	$	10,767	$	46,625	$	7,563	$	64,955
Less: income tax effect							9,878								11,617
Net stock-based compensation expense							$	53,788							$	53,338

Volterra Substitute Awards

In connection with the Volterra acquisition, the Company issued substitute awards to certain Volterra employees. Substitute awards included options to purchase approximately 673,185 shares of Maxim Integrated's common stock at a weighted-average grant date fair value of approximately $10.56 and a weighted-average exercise price of approximately $22.26 per share and also issued approximately 418,955 restricted stock units with a weighted-average grant date fair value of $29.53. The terms of these awards were substantially the same as those granted by Volterra. The intrinsic value of these awards was substantially the same immediately prior to and after the substitution as of October 1, 2013.

Stock Options

The fair value of options granted to employees under the Company’s Amended and Restated 1996 Stock Incentive Plan is estimated on the date of grant using the Black-Scholes option valuation model.

Expected volatilities are based on the historical volatilities from the Company’s traded common stock over a period equal to the expected term. The Company is utilizing the simplified method to estimate expected holding periods. The risk-free interest rate is based on the U.S. Treasury yield. The Company determines the dividend yield by dividing the annualized dividends per share by the prior quarter’s average stock price. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The fair value of options granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:



	Stock Options (1)
	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
Expected holding period (in years)	4.9		4.9		5.3		5.3
Risk-free interest rate	1.6	%	0.8	%	1.4	%	0.7	%
Expected stock price volatility	30.2	%	37.5	%	34.8	%	37.8	%
Dividend yield	3.6	%	3.4	%	3.2	%	3.3	%

(1) Table excludes impact from assumptions used in valuing the Volterra substitute options granted on October 1, 2013 based on an expected holding period of 3.8 years, risk-free interest rate of 1.0%, expected stock price volatility of 27.5% and dividend yield of 3.4%.

The weighted-average fair value of stock options granted was $5.55 and $7.39 per share for the three months ended March 29, 2014 and March 30, 2013, respectively. The weighted-average fair value of stock options granted was $7.39 and $6.69 per share for the nine months ended March 29, 2014 and March 30, 2013, respectively.

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 29, 2014 and their activity for the nine months ended March 29, 2014:



	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 29, 2013	20,081,339		$	26.00
Options Granted	2,882,740		27.17
Volterra substitute options granted	673,185		22.26
Options Exercised	(2,267,719	)	18.07
Options Cancelled	(3,042,128	)	32.25
Balance at March 29, 2014	18,327,417		$	26.04	3.6	$	148,116,516
Exercisable, March 29, 2014	8,592,118		$	27.62	1.9	$	69,970,388
Vested and expected to vest, March 29, 2014	17,245,995		$	26.01	3.5	$	141,248,804



(1)	Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 29, 2014.

As of March 29, 2014, there was $40.7 million of total unrecognized stock compensation cost related to 9.7 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 2.8 years.

As of March 30, 2013, there was $35.3 million of total unrecognized stock compensation cost related to 10.2 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 2.8 years.

Restricted Stock Units

The fair value of Restricted Stock Units (“RSUs”) under the Company’s Amended and Restated 1996 Stock Incentive Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The weighted-average fair value of RSUs granted was $29.57 and $29.48 per share for the three months ended March 29, 2014 and March 30, 2013, respectively. The weighted-average fair value of RSUs granted was $26.31 and $25.08 per share for the nine months ended March 29, 2014 and March 30, 2013, respectively.

The following table summarizes outstanding and expected to vest RSUs as of March 29, 2014 and their activity during the nine months ended March 29, 2014:



	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 29, 2013	7,965,532
Restricted stock units granted	3,387,079
Volterra substitute restricted stock units granted	418,955
Restricted stock units released	(2,141,883	)
Restricted stock units cancelled	(903,922	)
Balance at March 29, 2014	8,725,761		2.7	$	284,624,813
Outstanding and expected to vest, March 29, 2014	7,626,649		2.7	$	249,086,361



(1)	Aggregate intrinsic value for RSUs represents the closing price per share of the Company’s common stock on March 28, 2014, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 29, 2014.

The Company withheld shares totaling $8.4 million and $22.5 million in value as a result of employee withholding taxes based on the value of the RSUs on their vesting date for the three and nine months ended March 29, 2014, respectively. The total payments for the employees’ tax obligations to the taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.

As of March 29, 2014, there was $146.3 million of unrecognized compensation expense related to 8.7 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years.

As of March 30, 2013, there was $127.6 million of unrecognized compensation expense related to 8.7 million unvested RSUs, which is expected to be recognized over a weighted average period of approximately 2.7 years.

Employee Stock Purchase Plan

The fair value of rights to acquire common stock under the Company’s 2008 Employee Stock Purchase Plan (the “ESPP”) is estimated on the date of grant using the Black-Scholes option valuation model.

The fair value of ESPP granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following weighted-average assumptions:



	ESPP
	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
Expected holding period (in years)	0.5		0.5		0.5		0.5
Risk-free interest rate	0.1	%	0.1	%	0.1	%	0.1	%
Expected stock price volatility	21.7	%	26.1	%	21.7	%	26.1	%
Dividend yield	3.7	%	3.6	%	3.7	%	3.6	%

As of March 29, 2014, there was $4.9 million of unrecognized compensation expense related to the ESPP.

NOTE 7: EARNINGS PER SHARE

Basic earnings per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs. Diluted earnings per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs and assumed issuance of common stock under the employee stock purchase plans using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share:



	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
	(in thousands, except per share data)
Numerator for basic earnings per share and diluted earnings per share
Net income	$	122,544	$	131,388	$	270,017	$	335,898

Denominator for basic earnings per share	282,627		292,888		283,315		292,048
Effect of dilutive securities:
Stock options, ESPP and RSUs	5,948		7,194		5,807		6,773
Denominator for diluted earnings per share	288,575		300,082		289,122		298,821

Earnings per share: basic
From continuing operations	$	0.43	$	0.44	$	0.95	$	1.14
From discontinued operations	—		0.01		—		0.01
Basic	$	0.43	$	0.45	$	0.95	$	1.15

Earnings per share: diluted
From continuing operations	$	0.42	$	0.43	$	0.93	$	1.11
From discontinued operations	—		0.01		—		0.01
Diluted	$	0.42	$	0.44	$	0.93	$	1.12

Approximately 9.8 million and 9.0 million stock options were excluded from the calculation of diluted earnings per share for the three months ended March 29, 2014 and March 30, 2013, respectively. Approximately 9.8 million and 10.6 million stock options were excluded from the calculation of diluted earnings per share for the nine months ended March 29, 2014 and March 30, 2013, respectively. These options were excluded because they were determined to be antidilutive. However, such options could be dilutive in the future and, under those circumstances, would be included in the calculation of diluted earnings per share.

NOTE 8: SEGMENT INFORMATION

The Company operates and tracks its results in one reportable segment. The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. The Chief Executive Officer has been identified as the Chief Operating Decision Maker as defined by ASC No. 280, Segment Reporting (“ASC 280”).

The Company has three operating segments that aggregate into one reportable segment. Under ASC 280, two or more operating segments may be aggregated into a single operating segment for financial reporting purposes if aggregation is consistent with the objective and basic principles of ASC 280, if the segments have similar economic characteristics, and if the segments are similar in each of the following areas:


•	the nature of products and services;


•	the nature of the production processes;


•	the type or class of customer for their products and services; and


•	the methods used to distribute their products or provide their services.

The Company meets each of the aggregation criteria for the following reasons:


•	the sale of analog and mixed signal integrated circuits is the primary source of revenue for each of the Company’s three operating segments;


•	the integrated circuits sold by each of the Company’s operating segments are manufactured using similar semiconductor manufacturing processes;


•	the integrated circuits marketed by each of the Company’s operating segments are sold to the same types of customers; and


•	all of the Company’s integrated circuits are sold through a centralized sales force and common wholesale distributors.

All of the Company’s operating segments share similar long-term financial performance as they have similar economic characteristics, including gross margins. The causes for variation among the Company’s operating segments are the same and include factors such as (i) life cycle and price and cost fluctuations, (ii) number of competitors, (iii) product differentiation and (iv) size of market opportunity. Additionally, each operating segment is subject to the overall cyclical nature of the semiconductor industry. The number and composition of employees and the amounts and types of tools and materials required are similar for each operating segment. Finally, even though the Company periodically reorganizes the Company’s operating segments based upon changes in customers, end-markets or products, acquisitions, long-term growth strategies, and the experience and bandwidth of the senior executives in charge, the common financial goals for each operating segment remain constant.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each reporting period.

Net revenues from unaffiliated customers by geographic region were as follows:



	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
	(in thousands)
United States	$	68,944	$	63,784	$	241,082	$	185,765
China	240,677		225,808		745,886		767,192
Korea	33,217		73,362		101,979		194,357
Rest of Asia	160,703		151,231		444,270		425,904
Europe	84,005		75,734		230,032		213,582
Rest of World	18,135		14,965		47,947		46,465
	$	605,681	$	604,884	$	1,811,196	$	1,833,265

Net long-lived assets by geographic region were as follows:



	March 29, 2014		June 29, 2013
	(in thousands)
United States	$	1,057,881	$	1,058,579
Philippines	175,636		183,671
Rest of World	121,751		130,874
	$	1,355,268	$	1,373,124

NOTE 9: COMPREHENSIVE INCOME

The changes in accumulated other comprehensive loss by component and related tax effects in the nine months ended March 29, 2014 were as follows:



(in thousands)	Unrealized gain (loss) on intercompany receivables			Unrealized gain (loss) on post-retirement benefits			Cumulative translation adjustment			Unrealized gain (loss) on cash flow hedges			Unrealized gain (loss) on available-for-sale securities			Total
June 29, 2013	$	(7,401	)	$	(5,838	)	$	(1,527	)	$	(1,004	)	$	23		$	(15,747	)
Other comprehensive income (loss) before reclassifications	—			—			—			(465		)	(36		)	(501		)
Amounts reclassified out of accumulated other comprehensive income (loss)	—			1,076			—			1,525			—			2,601
Tax effects	1,742			(224		)	—			(190		)	13			1,341
Other comprehensive income (loss)	1,742			852			—			870			(23		)	3,441
March 29, 2014	$	(5,659	)	$	(4,986	)	$	(1,527	)	$	(134	)	$	—		$	(12,306	)

NOTE 10: INCOME TAXES

In the three and nine months ended March 29, 2014, the Company recorded an income tax provision (benefit) of $(10.6) million and $31.6 million, respectively, compared to an income tax provision of $22.8 million and $92.7 million in the three and nine months ended March 30, 2013, respectively. In addition, the Company recorded income tax that was netted against income from discontinued operations of $0.7 million for the three and nine months ended March 30, 2013. The Company’s effective tax rate for the three and nine months ended March 29, 2014 was (9.5)% and 10.5%, respectively, compared to 15.1% and 21.8%, respectively, for the three and nine months ended March 30, 2013.

The Company's federal statutory tax rate is 35%. The Company's effective tax rates for the three and nine months ended March 29, 2014 were lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by our Irish operations, were taxed at lower rates and a $34.6 million one-time discrete benefit for fixed asset tax basis adjustments related to prior year depreciation expense.

The Company’s effective tax rates for the three and nine months ended March 30, 2013 were lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by our Irish operations, were taxed at lower rates. The Company’s income tax provision for the three and nine months ended March 30, 2013 included a $7.1 million benefit for research tax credits for fiscal year 2012 and the first two quarters of fiscal year 2013 that were generated by the retroactive extension of the federal research tax credit to January 1, 2012 by legislation that was signed into law on January 2, 2013. The Company's income tax provision for the nine months ended March 30, 2013 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available.

The Company estimates it is reasonably possible that our liability for unrecognized tax benefits (income taxes payable), including accrued interest and penalties, could decrease within the next 12 months by $26 million due to expected settlements with various tax authorities.

The Company’s federal corporate income tax returns are audited on a recurring basis by the IRS. In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company's federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.

NOTE 11: COMMITMENTS AND CONTINGENCIES

Legal Proceedings

The Company is a party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual-property matters. While the outcome of these matters cannot be predicted with certainty, we do not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.

Indemnification

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees and damages and costs awarded against such parties in certain circumstances in which the Company’s products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company’s indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company’s potential liability for indemnification relating to intellectual property infringement claims.

Pursuant to the Company’s charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

Product Warranty

The Company generally warrants its products for one year from the date of shipment against defects in materials, workmanship and material non-conformance to the Company’s specifications. The general warranty policy provides for the repair or replacement of defective products or a credit to the customer’s account. In addition, the Company may consider its relationship with the customer when reviewing product claims. In limited circumstances and for strategic customers in certain unique industries and applications, our product warranty may extend for up to five years, and may also include financial responsibility, such as the payment of monetary compensation to reimburse a customer for its financial losses above and beyond repairing or replacing the product or crediting the customer’s account should the product not meet the Company’s specifications and losses and /or damages results from the defective product. The Company’s results of operations for the three months ended December 28, 2013 include a charge of $18.1 million primarily related to a product claim with a major customer. This charge includes product replacement and the cost to remove and install replacement product. Additionally, the Company assumed $13.9 million of warranty claims from Volterra in connection with the Company’s acquisition of Volterra on October 1, 2013.

Accruals are based on specifically identified claims and on the estimated, undiscounted cost of incurred-but-not-reported claims. If there is a material increase in the rate of customer claims compared with our historical experience or if the Company's estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty liability is included within the balance sheet captions “Accrued Expenses” and “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets.

The changes in the Company's aggregate product warranty liabilities for the nine months ended March 29, 2014 were as follows:



	(in thousands)
Product warranty liability at June 29, 2013	$	3,075
Accruals assumed from acquisition	13,911
Accruals for warranties	19,640
Payments	(12,776		)
Changes in estimate	187
Product warranty liability at March 29, 2014	$	24,037

NOTE 12: COMMON STOCK REPURCHASES

In July 2013, the Board of Directors authorized the Company to repurchase up to $1 billion of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company’s Board of Directors for the repurchase of common stock were superseded by this authorization.

During the nine months ended March 29, 2014, the Company repurchased approximately 9.2 million shares of its common stock based on settlement date for $264.6 million. As of March 29, 2014, the Company had remaining authorization of $802.6 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

NOTE 13: ACQUISITIONS

Acquisitions completed in fiscal year 2014

The Company completed two acquisitions during fiscal year 2014.

VOLTERRA

On October 1, 2013, the Company completed its acquisition of Volterra, formerly a publicly traded company that develops power management solutions. The primary reason for this acquisition was to expand the Company's available market across a wide range of end markets, including enterprise server, cloud computing, communications and energy. The results of operations of Volterra are included in the Company’s Condensed Consolidated Statements of Income, beginning in the second quarter of fiscal year 2014. Acquisition-related costs for the nine months ended March 29, 2014 were $7.0 million. The Company is in the process of integrating the Volterra acquisition with the existing Communications and Automotive Solutions Group.

The total purchase price for Volterra was approximately $615 million and was comprised of:



	(in thousands)
Cash consideration for 100% of outstanding common stock of Volterra at $23 per share	$	593,250
Cash consideration for vested options settlement	21,756
Total preliminary purchase price	$	615,006

Volterra Substitute Awards

In connection with the acquisition, the Company issued substitute awards to certain Volterra employees. Refer to Note 6: “Stock-Based Compensation” of these Notes to Condensed Consolidated Financial Statements for further discussion on stock compensation in relation to Volterra.

The preliminary purchase price allocation as of the date of the acquisition is set forth in the table below and reflects various fair value estimates and analysis. These estimates were determined through established and generally accepted valuation techniques, including preliminary work performed by third-party valuation specialists, and are subject to change during the purchase price allocation period (generally one year from the acquisition date) as valuations are finalized.



	Volterra
	(in thousands)
Cash and cash equivalents and short-term investments	$	163,500
Accounts receivable	23,453
Inventories	33,339
Other tangible assets	17,151
Accrued expenses	(35,343		)
Income taxes payable	(23,241		)
Other liabilities assumed	(20,149		)
Net tangible assets	158,710
Amortizable intangible assets	226,900
In-process research and development ("IPR&D")	56,200
Goodwill	174,894
Substitution of stock-based compensation awards	(1,698		)
Total purchase price	$	615,006

The fair value of property, plant, and equipment and intangible assets is preliminary pending the completion of the valuation of those assets. In addition, the Company has evaluated and continues to evaluate certain pre-acquisition contingencies, including corporate income tax related payables, uncertain tax positions and certain legal contingencies, relating to Volterra that existed as of the acquisition date. Additional information, which existed as of the acquisition date but was at that time unknown to the Company, may become known to the Company during the remainder of the purchase price allocation period.

IPR&D assets relate to future technology, is capitalized until the technology is ready for its intended use and then amortized over the technology useful life. IPR&D costs incurred by the Company subsequent to the acquisition are expensed.

Goodwill was primarily attributable to the opportunities from the addition of Volterra's product portfolio which complements the Company’s suite of products, including providing integrated process solutions to customers. The goodwill is not deductible for tax purposes.

The amortizable intangible assets are being amortized on a straight-line basis over their estimated useful lives as follows:



	Volterra acquisition
	Fair value ( in thousands)		Weighted average useful life (in years)
Intellectual property	$	192,500	4.9
Customer relationships	24,600		9.6
Trade name	6,400		4.0
Backlog	900		0.4
Patents	2,500		4.8
Total amortizable intangible assets	$	226,900

Pro forma results of operations for this acquisition have not been presented because it is not material to the Company's Condensed Consolidated Statements of Income.

Refer to Note 16: "Restructuring Activities" of these Notes to Condensed Consolidated Financial Statements for a discussion on Volterra Restructuring Plan.

OTHER ACQUISITION

The Company acquired another company during the nine months ended March 29, 2014, which develops low power high performance analog circuits. The total cash consideration in exchange for 100% of the outstanding shares, for this acquisition was

approximately $6.1 million for which the purchase price was largely attributable to the acquired developed intellectual property. Acquisition related costs were not material for this transaction.

NOTE 14: GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company performed the annual goodwill impairment analysis during the first quarter of fiscal year 2014 and concluded that goodwill was not impaired, as the fair value of each reporting unit exceeded its carrying value.

Activity and goodwill balances for the nine months ended March 29, 2014 were as follows:



	Goodwill
	(in thousands)
Balance at June 29, 2013	$	422,004
Acquisitions	175,493
Adjustments	179
Balance at March 29, 2014	$	597,676

Intangible Assets

The useful lives of amortizable intangible assets are as follows:



Asset		Life
Intellectual property		3 months-10 years
Customer relationships		5-10 years
Trade name		3-4 years
Backlog		4 months
Patents		5 years

Intangible assets consisted of the following:



	March 29, 2014						June 29, 2013
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	435,962	$	182,773	$	253,189	$	230,562	$	136,870	$	93,692
Customer relationships	120,230		65,262		54,968		95,230		54,308		40,922
Tradename	8,500		2,836		5,664		2,100		1,950		150
Backlog	1,000		1,000		—		—		—		—
Patent	2,500		256		2,244		—		—		—
Total amortizable purchased intangible assets	568,192		252,127		316,065		327,892		193,128		134,764
IPR&D	68,102		—		68,102		22,382		—		22,382
Total purchased intangible assets	$	636,294	$	252,127	$	384,167	$	350,274	$	193,128	$	157,146

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:



	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
	(in thousands)
Cost of goods sold	$	18,542	$	7,777	$	45,732	$	26,217
Intangible asset amortization	4,863		3,903		13,267		11,855
Total intangible asset amortization expenses	$	23,405	$	11,680	$	58,999	$	38,072

The following table represents the estimated future amortization expense of intangible assets as of March 29, 2014:



Fiscal Year	Amount
	(in thousands)
Remaining three months of 2014	$	23,172
2015	90,443
2016	74,454
2017	61,782
2018	41,927
2019	13,278
Thereafter	11,009
Total intangible assets	$	316,065

NOTE 15: IMPAIRMENT OF LONG-LIVED ASSETS

Fiscal year 2014:

During the second quarter of fiscal year 2014, the Company recorded $5.2 million in Impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income.

The impairment includes certain U.S. test operation assets identified as excess and no longer needed. These assets included primarily test manufacturing equipment which was recorded in Property, plant, and equipment, net in the Condensed Consolidated Balance Sheet as of March 29, 2014. The company also impaired fab tools and a building classified as held for sale. The fab tools were fully impaired while the building was impaired down to fair value less cost to sell. The fair value of the building was determined mainly after consideration of evidence such as broker estimates, building condition, and offers received.

Fiscal year 2013:

During the second quarter of fiscal year 2013, the Company identified certain assets as excess primarily attributable to the transition to utilizing newer, more efficient manufacturing equipment. These assets included used fabrication tools and test manufacturing equipment. In connection with these circumstances, the Company recorded a charge for the write down of equipment to its estimated fair value. The total charge of $22.2 million was included in Impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income. The Company reached its conclusion regarding the asset impairment after conducting an evaluation of assets fair values. The fair value of the equipment was determined mainly after consideration of quoted market prices of similar equipment adjusted for equipment specifications and condition in addition to the current market demand and size.

During the first quarter of fiscal year 2013, the Company identified certain idle facilities as held for sale. In connection with these circumstances, the Company recorded a charge for the write-down of land and buildings to their estimated fair value, less cost to sell. The total charge of $2.7 million was included in impairment of long-lived assets in the Company's Condensed Consolidated Statements of Income. The Company reached its conclusion regarding the asset impairment after conducting an evaluation of assets fair values. The fair value of the land and buildings was determined mainly after consideration of evidence such as appraisals and offers received.

NOTE 16: RESTRUCTURING ACTIVITIES

Volterra Restructuring Plan

In connection with the acquisitions of Volterra, the Company's management approved and initiated plans to restructure the operations of Volterra, including acceleration of certain stock-based compensation awards, costs to vacate duplicative facilities, severance for transitional and exiting employees, contract cancellation costs and other items. The total combined cost of the plan was $10.6 million in Severance and restructuring expenses in the Company's Condensed Consolidated Statements of Income. As of March 29, 2014, the Company recorded all of the costs of the plan based upon the anticipated timing of planned terminations and facility closure costs. Expected severance and retention costs for transitional employees are being accrued over the transitional period. Amounts accrued and future estimated costs to be incurred as of March 29, 2014 are immaterial.

Business Unit Reorganization

During the nine months ended March 29, 2014, the Company recorded $8.5 million in Severance and restructuring expenses in the Company's Condensed Consolidated Statements of Income associated with the reorganization of certain business units. Multiple job classifications and locations were impacted as this was a company-wide action. The reorganization was driven by the desire to focus on specific investment areas and simplify business processes.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Maxim Integrated Products, Inc. (“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) disclaims any duty to and undertakes no obligation to update any forward-looking statement, whether as a result of new information relating to existing conditions, future events or otherwise or to release publicly the results of any future revisions it may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by federal securities laws. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date of this Quarterly Report on Form 10-Q. Readers should carefully review future reports and documents that the Company files with or furnishes to the SEC from time to time, such as its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K.

Overview of Business

Maxim Integrated is incorporated in the state of Delaware. Maxim Integrated designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of geographically diverse customers. The Company also provides a range of high-frequency process technologies and capabilities that can be used in custom designs. The analog market is fragmented and characterized by many diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. The Company is a global company with wafer manufacturing facilities in the U.S., testing facilities in the Philippines and Thailand and sales and circuit design offices throughout the world. The major end-markets in which the Company’s products are sold are the communications, computing, consumer and industrial markets.

On October 1, 2013, the Company completed the acquisition of Volterra Semiconductor Corporation (“Volterra”), a company that develops power management solutions, for approximately $615.0 million. The acquisition of Volterra expands our serviceable available market across a wide range of end markets, including enterprise server, cloud computing and communications.

CRITICAL ACCOUNTING POLICIES

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our condensed consolidated financial statements. The SEC has defined the most critical accounting policies as the ones that are most important to the portrayal of our financial condition and results of operations, and that require us to make our most difficult and subjective accounting judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our most critical accounting policies include revenue recognition and related allowances, which impact the recording of revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts write-offs of fixed assets, intangible assets, and goodwill; accounting for stock-based compensation, which impacts cost of goods sold, gross margins and operating expenses; accounting for income taxes, which impacts the income tax provision; and assessment of contingencies, which impacts charges recorded in cost of goods sold and operating expenses. We have other significant accounting policies that either do not generally require estimates and judgments that are as difficult or subjective, or are less likely to have a material impact on our reported results of operations for a given period.

There have been no material changes during the nine months ended March 29, 2014 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 29, 2013.

RESULTS OF OPERATIONS

The following table sets forth certain Condensed Consolidated Statements of Income data expressed as a percentage of net revenues for the periods indicated:



	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013

Net revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of goods sold	43.9	%	37.8	%	43.9	%	38.6	%
Gross margin	56.1	%	62.2	%	56.1	%	61.4	%
Operating expenses:
Research and development	23.4	%	22.2	%	22.9	%	22.0	%
Selling, general and administrative	13.3	%	13.5	%	13.3	%	13.2	%
Intangible asset amortization	0.8	%	0.6	%	0.7	%	0.6	%
Impairment of long-lived assets	—	%	—	%	0.3	%	1.4	%
Severance and restructuring expenses	0.6	%	—	%	1.1	%	0.1	%
Acquisition-related costs	—	%	—	%	0.4	%	—	%
Other operating expenses (income), net	0.5	%	0.4	%	0.5	%	0.2	%
Total operating expenses	38.6	%	36.7	%	39.2	%	37.5	%
Operating income	17.5	%	25.5	%	16.9	%	23.9	%
Interest and other income (expense), net	0.9	%	(0.4	)%	(0.2	)%	(0.6	)%
Income before provision for income taxes	18.4	%	25.1	%	16.7	%	23.3	%
Income tax provision (benefit)	(1.8	)%	3.8	%	1.7	%	5.1	%
Income from continuing operations	20.2	%	21.3	%	15.0	%	18.2	%
Income from discontinued operations, net of tax	—	%	0.4	%	—	%	0.1	%
Net income	20.2	%	21.7	%	15.0	%	18.3	%

The following table shows stock-based compensation included in the components of the Condensed Consolidated Statements of Income reported above as a percentage of net revenues for the periods indicated:



	Three Months Ended				Nine Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013

Cost of goods sold	0.5	%	0.5	%	0.5	%	0.5	%
Research and development	1.9	%	1.7	%	1.9	%	1.9	%
Selling, general and administrative	1.2	%	1.1	%	1.1	%	1.1	%
	3.6	%	3.3	%	3.5	%	3.5	%

Net Revenues

Net revenues were $605.7 million and $604.9 million for the three months ended March 29, 2014 and March 30, 2013, respectively, an increase of less than 1%. Net revenues were $1,811.2 million and $1,833.3 million for the nine months ended March 29, 2014 and March 30, 2013, respectively, a decrease of 1.2%. We classify our shipments by four major end markets: Communications, Computing, Consumer and Industrial. Net shipments increased during the three months ended March 29, 2014 as compared to the three months ended March 30, 2013 due to an increase in shipments of our industrial products portfolio driven primarily by products offered in the automotive market, a net increase in shipments to the computing end market due to the Volterra acquisition, as well as an increase in demand for cable infrastructure products, network and datacom in the communication end market. These increases were partially offset by lower demand for products in the consumer end market primarily from smartphones. Net shipments

decreased during the nine months ended March 29, 2014 as compared to the nine months ended March 30, 2013 due to lower demand for products in the consumer end market primarily from smartphones. This decrease was partially offset by an increase in shipments of our industrial products portfolio driven primarily by products offered in the automotive market, an increase in demand for cable infrastructure products, network and datacom in the communication end market, as well as a net increase in shipments to the computing end market due to the Volterra acquisition.

During the three months ended March 29, 2014 and March 30, 2013, approximately 89% of net revenues were derived from customers outside of the United States. During the nine months ended March 29, 2014 and March 30, 2013, approximately 87% and 90% of net revenues, respectively, were derived from customers outside of the United States. While more than 95% of these sales are denominated in U.S. Dollars, we enter into foreign currency forward contracts to mitigate our risks on firm commitments and net monetary assets and liabilities denominated in foreign currencies. The impact of changes in foreign exchange rates on our revenue and results of operations for the three and nine months ended March 29, 2014 and March 30, 2013 was immaterial.

Gross Margin

Our gross margin percentages were 56.1% and 62.2% for the three months ended March 29, 2014 and March 30, 2013, respectively. Gross margin decreased due to a $10.0 million increase in incremental amortization related to Volterra intangible assets, a $5.5 million increase related to previous acquisitions inventory fair value mark-up amortization, and a $5.2 million increase in inventory reserves.

Our gross margin percentages were 56.1% and 61.4% for the nine months ended March 29, 2014 and March 30, 2013, respectively. Gross margin decreased due to $20.2 million of product warranty related expenses primarily associated with one customer, $21.1 million of incremental amortization primarily related to the acquired Volterra intangible assets, $18.6 million related primarily to the Volterra acquired inventory fair value mark-up amortization mostly related to Volterra, and increased inventory reserves of $14.5 million.

Research and Development

Research and development expenses were $141.5 million and $134.1 million for the three months ended March 29, 2014 and March 30, 2013, respectively, which represented 23.4% and 22.2% of net revenues for each respective period. The $7.4 million increase was primarily attributable to a $6.7 million increase in salaries and related expenses primarily resulting from the Volterra acquisition and annual salary adjustments, and was partially offset by headcount reductions due to restructuring programs implemented in fiscal year 2014.

Research and development expenses were $414.4 million and $402.8 million for the nine months ended March 29, 2014 and March 30, 2013, respectively, which represented 22.9% and 22.0% of net revenues for each respective period. The $11.6 million increase was primarily attributable to a $7.8 million increase in salaries and related expenses primarily resulting from the Volterra acquisition and annual salary adjustments, and was partially offset by headcount reductions due to restructuring programs implemented in fiscal year 2014.

Selling, General and Administrative

Selling, general and administrative expenses were $80.7 million and $82.0 million for the three months ended March 29, 2014 and March 30, 2013, respectively, which represented 13.3% and 13.5% of net revenues for each respective period. There were no significant fluctuations in line items making up the selling, general and administrative expenses.

Selling, general and administrative expenses were relatively flat at $241.6 million and $242.2 million for the nine months ended March 29, 2014 and March 30, 2013, respectively, which represented 13.3% and 13.2% of net revenues for each respective period. There were no significant fluctuations in line items making up the selling, general and administrative expenses.

Impairment of Long-Lived Assets

Impairment of long-lived assets were $5.2 million and $24.9 million for the nine months ended March 29, 2014 and March 30, 2013, respectively, which represented 0.3% and 1.4% of net revenues, respectively. The $19.7 million decrease was primarily due to lower levels of certain assets classified as excess Property, plant and equipment and certain assets classified as held for sale written down to fair value less cost to sell in the nine months ended March 30, 2013 as compared to the nine months ended March 29, 2014.

Severance and Restructuring Expenses

Severance and restructuring expenses were $3.3 million and $0.2 million for the three months ended March 29, 2014 and March 30, 2013, respectively, which represented 0.6% and 0.0% of net revenues for each respective period. The $3.1 million increase was primarily due to restructuring costs associated with restructuring plans arising from the Volterra acquisition and the reorganization of certain business units. The reorganizations were driven by the desire to focus on specific investment areas and simplify business processes.

Severance and restructuring expenses were $19.1 million and $2.4 million for the nine months ended March 29, 2014 and March 30, 2013, respectively, which represented 1.1% and 0.1% of net revenues for each respective period. The $16.7 million increase was primarily due to a $11.6 million increase in severance costs associated with restructuring plans arising from the Volterra acquisition and a $5.1 million increase in severance and restructuring expenses associated with the reorganization of certain business units.

Acquisition-Related Costs

Acquisition-related costs were $(0.1) million and $7.0 million for the three and nine months ended March 29, 2014, respectively, and included banker, legal, and other Volterra acquisition-related costs.

Other Operating Expenses (Income), net

Other operating expenses (income), net were $2.9 million and $1.7 million during the three months ended March 29, 2014 and March 30, 2013, respectively. This net increase in expense of $1.2 million was primarily driven by in-process research and development abandoned.

Other operating expenses (income), net were $9.6 million and $3.8 million during the nine months ended March 29, 2014 and March 30, 2013, respectively. This $5.8 million increase was primarily attributable to a $6.0 million intellectual property infringement legal settlement and in-process research and development abandoned.

Interest and Other Income (Expense), net

Interest and other income (expense), net were $5.2 million and $(2.7) million for the three months ended March 29, 2014 and March 30, 2013, respectively. This net increase in income of $7.9 million was primarily driven by income from licensing intellectual property of $16.8 million offset by $4.1 million more interest expense on long-term notes issued November 2013.

Interest and other income (expense), net were $(4.1) million and $(11.2) million for the nine months ended March 29, 2014 and March 30, 2013, respectively. This net decrease in expenses of $7.1 million was primarily driven by income from licensing intellectual property of $16.8 million offset by $9.3 million in additional interest expense resulting from the issuance of long-term notes in November 2013.

Provision for Income Taxes

The Company’s effective tax rate for the three and nine months ended March 30, 2013 were lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by our Irish operations, were taxed at lower rates. The Company’s income tax provision for the three and nine months ended March 30, 2013 included a $7.1 million benefit for research tax credits for fiscal year 2012 and the first two quarters of fiscal year 2013 that were generated by the retroactive extension of the federal research tax credit to January 1, 2012 by legislation that was signed into law on January 2, 2013. The Company's

income tax provision for the nine months ended March 30, 2013 included a $21.4 million discrete tax charge for research and development expenses of a foreign subsidiary for which no tax benefit was available.

The effective tax rate changes for the three and nine months ended March 29, 2014 and March 30, 2013 are primarily due to shifts of income and loss among jurisdictions with differing tax rates, a $21.4 million discrete tax charge in the nine months ended March 30, 2013 for research and development expenses of a foreign subsidiary for which no tax benefit was available, and a $34.6 million one-time discrete benefit in the three and nine months ended March 29, 2014 for fixed asset tax basis adjustments related to prior year depreciation expense.

BACKLOG

At March 29, 2014 and December 28, 2013, our current quarter backlog was approximately $413 million and $366 million, respectively. We include in backlog orders with customer request dates within the next three months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to customers. In addition, backlog includes orders from domestic distributors for which revenues are not recognized until the products are sold by the distributors. Accordingly, we believe that our backlog is not a reliable measure of future revenues. All backlog numbers have been adjusted for estimated future distribution ship and debit pricing adjustments.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Financial Condition

Cash flows were as follows:



	Nine Months Ended
	March 29, 2014			March 30, 2013
	(in thousands)
Net cash provided by (used in) operating activities	$	542,023		$	603,535
Net cash provided by (used in) investing activities	(537,459		)	(103,092		)
Net cash provided by (used in) financing activities	51,698			166,477
Net increase (decrease) in cash and cash equivalents	$	56,262		$	666,920

Operating activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities.

Cash from operations for the nine months ended March 29, 2014 decreased by approximately $61.5 million compared to the nine months ended March 30, 2013. This was primarily due to a $65.9 million decrease in net income, but was partially offset by net cash inflows from working capital changes.

Investing activities

Investing cash flows consist primarily of capital expenditures, net investment purchases and maturities and acquisitions.

Cash used in investing activities decreased by $434.4 million for the nine months ended March 29, 2014 compared with the nine months ended March 30, 2013. The decrease was primarily due to the payment of $459.3 million (net of cash acquired) in connection with fiscal year 2014 acquisitions, primarily related to the Volterra acquisition.

Financing activities

Financing cash flows consist primarily of debt issuance, repurchases of common stock and payment of dividends to stockholders.

Net cash provided by financing activities decreased by approximately $114.8 million for the nine months ended March 29, 2014 compared to the nine months ended March 30, 2013. The decrease was primarily due to an $82.7 million increase in repurchases of our common stock and a $21.9 million reduction in proceeds received from the exercise of stock options.

Liquidity and Capital Resources

Debt Levels

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% senior unsecured and unsubordinated notes due on November 15, 2018.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due on March 15, 2023.

Outstanding debt has increased to $1,003 million from $506 million as of March 29, 2014 and June 29, 2013, respectively, bearing weighted average interest rate of 3.0% and 3.5% for the nine months ended March 29, 2014 and for the year ended June 29, 2013, respectively.

Available Financing Resources

As of March 29, 2014, the Company had the capacity to issue an unspecified amount of additional debt securities, common stock, preferred stock, warrants, rights and units under an automatic shelf registration statement filed with the SEC on August 12, 2013.

The Company also has access to a $250 million senior unsecured revolving credit facility with certain institutional lenders that expires on October 13, 2016. The facility fee is at a rate per annum that varies based on the Company's index debt rating and any advances under the credit agreement will accrue interest at a base rate plus a margin based on the Company's index debt rating. As of March 29, 2014, the Company had not borrowed any amounts from this credit facility and was in compliance with all debt covenants.

As of March 29, 2014, our available funds consisted of $1,231.2 million in cash and cash equivalents.

The Company believes that its existing sources of liquidity and cash expected to be generated from future operations, together with existing and available borrowing resources if needed, will be sufficient to fund operations, capital expenditures, research and development efforts, dividend payments, common stock repurchases, debt repayments and acquisitions for at least the next twelve months.

Off-Balance-Sheet Arrangements

As of March 29, 2014, the Company did not have any material off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company’s market risk has not changed materially from the interest rate and foreign currency risks disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 29, 2013.

The impact of inflation and changing prices on the Company’s net revenues and on operating income during the nine months ended March 29, 2014 and March 30, 2013 was not material.

ITEM 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act") as of March 29, 2014. Our management, including the CEO and the CFO, has concluded that the Company’s disclosure controls and procedures were effective as of March 29, 2014. The purpose of these controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded,

processed, summarized and reported within the time periods specified in the SEC’s rules, and that such information is accumulated and communicated to our management, including our CEO and our CFO, to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

On October 1, 2013 we completed the acquisition of Volterra. We are in the process of integrating Volterra into our systems and control environment as of March 29, 2014. There were no other changes in our internal control over financial reporting during the quarter ended March 29, 2014, which were identified in connection with management's evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected or are reasonable likely to materially affect our internal control over financial reporting.

Inherent Limitations on the Effectiveness of Internal Controls

A system of internal control over financial reporting is intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with GAAP and no control system, no matter how well designed and operated, can provide absolute assurance. The design of any control system is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement errors and misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

PART II. OTHER INFORMATION

ITEM 1: LEGAL PROCEEDINGS

The information set forth above under Part I, Item 1, Note 11 “Commitment and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.

ITEM 1A: RISK FACTORS

A description of risks associated with our business, financial condition and results of our operations is set forth in Item 1A - Risk Factors of our Annual Report on Form 10-K for the fiscal year ended June 29, 2013, which is incorporated herein by reference.

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table summarizes the activity related to stock repurchases for the three months ended March 29, 2014:



	Issuer Repurchases of Equity Securities
	(in thousands, except per share amounts)
	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
Dec. 29, 2013 - Jan. 25, 2014	577	$	28.40	577	$	837,294
Jan. 26, 2014 - Feb. 22, 2014	564	29.85		564	820,467
Feb. 23, 2014 - Mar. 29, 2014	555	32.20		555	802,612
Total for the quarter	1,696	$	30.12	1,696	$	802,612

On July 25, 2013, the Board of Directors authorized the Company to repurchase up to $1 billion of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company’s Board of Directors for the repurchase of common stock were superseded by this authorization.

In the fiscal quarter ended March 29, 2014, the Company repurchased approximately 1.7 million shares of its common stock based on settlement date for approximately $51.1 million. As of March 29, 2014, the Company had remaining authorization of $802.6 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

ITEM 3: DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4: MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5: OTHER INFORMATION

None

ITEM 6: EXHIBITS

(a) Exhibits



31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 (1)
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 (1)
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document



(1) This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three and nine months ended March 29, 2014, (ii) Condensed Consolidated Balance Sheets at March 29, 2014 and June 29, 2013, (iii) Condensed Consolidated Statement of Comprehensive Income for the three and nine months ended March 29, 2014, (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended March 29, 2014 and (v) Notes to Condensed Consolidated Financial Statements.

In accordance with Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the report has been signed below by the following person on behalf of the registrant and in the capacity indicated.



April 25, 2014		MAXIM INTEGRATED PRODUCTS, INC.

		By:/s/ David A. Caron

		David A. Caron
		Vice President and Principal Accounting Officer
		(Chief Accounting Officer and Duly Authorized Officer)